Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesLudwig Kappos, Rupert Sandbrink, Chris H. Polman et al.|American Journal of Ophthalmology|2006Cited by 551
Neurofilament ELISA validationAxel Petzold, George P. Paraskevas, Ayşe Altıntaş et al.|Journal of Immunological Methods|2009Cited by 105
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce Cree, Piotr Sokolowski, Gary Cutter et al.|The Lancet Neurology|2020Cited by 104
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple SclerosisLudwig Kappos, Krzysztof Selmaj, David K.B. Li et al.|JAMA Neurology|2016Cited by 103
Vitamin D, smoking, EBV, and long-term cognitive performance in MSMarianna Cortese, Kassandra L. Munger, Elena H. Martínez-Lapiscina et al.|Neurology|2020Cited by 58